PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target

Activation of peroxisome proliferator-activated receptors (PPARs), and particularly of PPARα and PPARγ, using selective agonists, is currently used in the treatment of metabolic diseases such as hypertriglyceridemia and type 2 diabetes mellitus. PPARα and PPARγ anti-inflammatory, antiproliferative a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tesse, Angela, Andriantsitohaina, Ramaroson, Ragot, Thierry
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2009
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659552/
https://ncbi.nlm.nih.gov/pubmed/19325917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/745821
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares